Richard T. Silver MD Myeloproliferative Neoplasms Center

Open Clinical Trials

An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects with Polycythemia Vera

Diseases:

Myeloproliferative Neoplasms, Polycythemia Vera

Location(s):

Upper East Side - Manhattan

Primary Investigator(s):

Ellen K. Ritchie, MD

A Two-tiered, Phase II, Rule-based, Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib (TEW-7197) for the Treatment of Anemic Patients with Philadelphia Chromosome-negative Myeloproliferative Neoplasms

Diseases:

Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Essential Thrombocythemia, Myelofibrosis, Polycythemia Vera

Location(s):

Upper East Side - Manhattan

Primary Investigator(s):

Joseph Scandura, MD, PhD

(646) 962-2727

Request an Appointment Medical Records Make a Difference Email List

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021 SilverMPNCenter@med.cornell.edu